当前位置:首页 - 行情中心 - 恩华药业(002262) - 财务分析 - 资产负债表

恩华药业

(002262)

  

流通市值:215.33亿  总市值:246.05亿
流通股本:8.82亿   总股本:10.08亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金1,635,420,861.42,158,946,445.072,066,306,976.551,951,247,359.13
应收票据及应收账款1,117,797,379.751,034,736,344.97934,067,437.87930,547,616.26
应收账款1,117,797,379.751,034,736,344.97934,067,437.87930,547,616.26
应收款项融资8,384,130.8518,767,867.9111,870,521.3828,205,518.31
预付款项32,102,993.2236,630,481.7254,753,223.254,066,008.64
其他应收款合计61,229,562.9122,480,668.479,767,106.2879,655,216.6
存货578,955,190.48628,637,457.97681,073,410.55703,982,234.42
其他流动资产7,498,961.0319,362,087.698,053,806.766,735,481.41
流动资产平衡项目0000
流动资产合计5,472,389,079.645,254,561,353.735,163,192,482.594,884,439,434.77
非流动资产:
长期股权投资72,990,868.3472,546,491.373,401,484.3474,752,877.74
其他权益工具投资34,223,290.9434,223,290.9440,221,090.4840,221,090.48
投资性房地产50,006,894.7650,515,884.8750,843,341.2251,437,087.48
固定资产1,118,723,912.121,141,155,669.511,122,211,023.861,125,758,665.71
在建工程301,622,281.92293,759,756.28117,809,875.4104,766,253.07
使用权资产61,226,266.7561,084,950.7952,374,562.7358,483,325.12
无形资产186,253,264.53190,465,599.14194,835,510.32198,855,205.07
开发支出90,574,106.0385,696,303.6571,530,887.5965,482,269.74
长期待摊费用101,621,594.5642,334,834.9644,492,885.9246,722,727.07
递延所得税资产59,374,408.1958,320,073.9451,821,116.2148,791,193.06
其他非流动资产54,948,848.3843,531,159.56156,430,949.65130,932,844.46
非流动资产平衡项目0000
非流动资产合计2,131,565,736.522,073,634,014.941,975,972,727.721,946,203,539
资产平衡项目0000
资产总计7,603,954,816.167,328,195,368.677,139,165,210.316,830,642,973.77
流动负债:
短期借款65,000,00055,000,00030,000,00030,000,000
应付票据及应付账款309,365,404.69277,198,717.73326,812,416.42256,295,924.64
其中:应付票据52,472,292.9760,915,202.2128,062,123.113,740,573.09
应付账款256,893,111.72216,283,515.52298,750,293.32242,555,351.55
预收款项--20,670,387.1423,900,402.33
合同负债21,173,046.3326,487,143.7725,951,986.1924,992,094.1
应付职工薪酬471.873,095,9267,599.81-
应交税费133,687,363.75159,550,075.41179,612,413.33145,453,849.74
其他应付款合计273,749,580.64269,702,653.44179,677,933.9306,361,522.54
一年内到期的非流动负债18,711,701.1420,855,915.3127,426,097.3920,459,145.65
其他流动负债1,789,510.612,137,399.312,181,974.152,033,870.68
流动负债平衡项目0000
流动负债合计823,477,079.03814,027,830.97792,340,808.33809,496,809.68
非流动负债:
长期借款230,000230,000230,000230,000
租赁负债38,689,935.5435,557,443.5321,636,359.7834,956,667.49
预计负债12,946,109.5312,946,109.53--
递延收益53,865,250.2753,865,250.2758,047,850.3758,047,850.37
递延所得税负债-1,461,068.99256,999.61264,726.37
非流动负债平衡项目0000
非流动负债合计105,731,295.34104,059,872.3280,171,209.7693,499,244.23
负债平衡项目0000
负债合计929,208,374.37918,087,703.29872,512,018.09902,996,053.91
所有者权益(或股东权益):
实收资本(或股本)1,007,588,0921,007,588,0921,007,588,0921,007,588,092
资本公积102,985,798.31102,985,798.31119,410,371.18119,410,371.18
其他综合收益6,754,407.196,754,407.1913,103,301.5913,103,301.59
盈余公积503,794,046503,794,046503,794,046503,794,046
未分配利润5,078,301,392.014,813,019,143.984,662,476,502.634,321,538,209.2
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计6,699,423,735.516,434,141,487.486,306,372,313.45,965,434,019.97
少数股东权益-24,677,293.72-24,033,822.1-39,719,121.18-37,787,100.11
股东权益平衡项目0000
股东权益合计6,674,746,441.796,410,107,665.386,266,653,192.225,927,646,919.86
负债和股东权益合计7,603,954,816.167,328,195,368.677,139,165,210.316,830,642,973.77
公告日期2024-04-202024-03-302023-10-262023-07-31
审计意见(境内)标准无保留意见
TOP↑